William E. Evans, PharmD, Faculty Member at  St. Jude Children’s Research Hospital to Serve as BPS Chair

Washington, D.C. – The Board of Pharmacy Specialties (BPS), is pleased to announce their officers and new Board members for 2016.

2016 Officers

William E. Evans, PharmD will serve as the 2016 Chair of the Board of Pharmacy Specialties. Dr. Evans is a faculty member at St. Jude Children’s Research Hospital. He joined St. Jude as a University of Tennessee pharmacy student in 1972, where he most recently served as President and CEO (2004-2014). For the past 38 years, his research has focused on the pharmacogenomics of anticancer agents in children, for which he has received three consecutive NIH MERIT Awards. The major disease focus of his research is acute lymphoblastic leukemia, the most common cancer in children. Dr. Evans has authored over 350 articles and numerous book chapters and has received several national awards, including the 2009 ASCO Pediatric Oncology Award (shared with Mary V. Relling), the 2009 AACR Team Science Prize (shared with SJCRH colleagues), the 2012 APhA Remington Honor Medal and the 2013 ASCPT Hunter Award. He is recognized as an ISI “Highly Cited Scientist” and was elected to the Institute of Medicine in 2002. During his tenure as CEO, St. Jude was ranked annually in the top 10 best places to work in academia by The Scientist magazine, ranked #1 children’s cancer hospital by Parents Magazine and US News and World Report, and listed by FORTUNE magazine among the top 100 companies to work for in the US annually since 2011. St. Jude is the only NCI-designated comprehensive cancer center devoted solely to children, and received the top rating of “exceptional” during its 2013 site visit by NCI.

Harold N. Godwin, RPh, MS will serve as the 2016 BPS Chair-elect and will assume the BPS Chairmanship in 2017. Harold Godwin is Associate Dean for Medical Affairs and Professor at the University of Kansas, School of Pharmacy. He earned a B.S. in Pharmacy from the University of Kansas, School of Pharmacy, M.S. in Hospital Pharmacy from The Ohio State University College of Pharmacy, and completed a two-year residency in pharmacy administration at The Ohio State University Hospitals. Godwin served 34 years as director of pharmacy at the KU Medical Center and 20 years as chair of the Department of Pharmacy Practice. He has been involved in pharmacy organizations throughout his career and has served as president of the Kansas Pharmacists Association, president of the American Society of Health System Pharmacists (ASHP), president of Accreditation Council for Pharmacy Education (ACPE), and president of the American Pharmacists Association (APhA).

Godwin’s research has included the development of innovative services in health-system practice and community practice. He has been interested in aspects of leadership development in the profession. From a patient-care standpoint, he has been interested in medication therapy management (MTM), health literacy, and patient medication adherence or compliance.

John A. Pieper, PharmD, FCCP, FAPhA will serve as the Immediate Past Chair of the Board of Pharmacy Specialties in 2016 and was re-appointed to a three year term as a non-specialist pharmacist member of the BPS Board of Directors. John A. Pieper is President and Professor at St. Louis College of Pharmacy.  Prior to his appointment in 2010, Dr. Pieper served as Dean and Professor of the College of Pharmacy and Vice President for Research at the University of New Mexico Health Sciences Center.  He has also served as Chairman of the Division of Pharmacotherapy, School of Pharmacy at the University of North Carolina at Chapel Hill and as Associate Dean for Clinical Programs and chair of the Department of Pharmacy Practice at the School of Pharmacy, University of Colorado.   Dr. Pieper received a B.A. degree in Molecular Biology from the University of Colorado, a B.S. in Pharmacy from the University of Wyoming and a Pharm.D. and post-doctoral fellowship training at the School of Pharmacy, State University of New York at Buffalo.  He is a past president of the American College of Clinical Pharmacy, past Speaker of the House of Delegates of the American Association of Colleges of Pharmacy and was recognized by the American Pharmacists Association as the Outstanding Pharmacy Dean in the United States in 2006.  He is a fellow of the American College of Clinical Pharmacy and the American Pharmacists Association.


New Board Members

The following individuals were appointed to three-year terms on the BPS Board of Directors, beginning January 1, 2016:

James A. Ponto, MS, RPh, BCNP, was re-appointed to a three-year term as a Board Certified Pharmacist member of the BPS Board of Directors. Ponto is Chief Nuclear Pharmacist at the University of Iowa Hospitals and Clinics, and Clinical Professor in the University of Iowa College of Pharmacy. He received his BS Pharmacy degree from the University of Iowa in 1977, and his MS Radiopharmacy degree from the University of Southern California in 1978. He has served two terms on the Nuclear Pharmacy Specialty Council, including three as Chair. He also served two terms as a non-specialist member on the Nutrition Support Specialty Council.

Karen M. Gunning, PharmD, BCPS, BCACP, FCCP was appointed to an initial three year term and will serve as a Board Certified Pharmacist member of the BPS Board of Directors. Dr. Gunning currently holds appointments as Professor and Interim Department Chair, Department of Pharmacotherapy and Adjunct Professor of Family and Preventive Medicine, University of Utah College of Pharmacy and School of Medicine. Dr. Gunning is dual certified in both Pharmacotherapy and Ambulatory Care. She is a Past Chair of the BPS Pharmacotherapy Specialty Council.

Dr. Gunning’s clinical practice is at the University of Utah Sugarhouse Family Health Center, a residency training site for the University of Utah Family Medicine Residency Program. She provides direct patient care services for chronic disease management as a part of an interprofessional team, teaches pharmacy, physician assistant and medical students, and is the program director of the University of Utah Healthcare PGY 2 Ambulatory Care Pharmacy Residency. Research interests include curriculum development for pharmacists and medical residents regarding changing models of care delivery, medication safety in the patient centered medical home (PCMH), the impact of pharmacists and the interdisciplinary team on costs, outcomes and efficiency in the PCMH, and the impact of ambulatory care pharmacist engagement in transitions of care.

Terry McInnis, MD, MPH, CPE, FACOEM was appointed to the BPS Board of Directors as the Physician Member. Dr. McInnis is President and Founder of Blue Thorn Inc. McInnis’ 25-plus year career spans practice and executive roles as a physician in both civilian and military settings. As president of Blue Thorn Inc., she partners with providers, professional organizations, health plans and government on the critical delivery system roadmap and financial realignment necessary for transformation to a viable health care model. Her leadership in the Patient-Centered Primary Care Collaborative resulted in the successful launch and widespread adoption of the PCPCC Resource Guide: Integrating Comprehensive Medication Management to Optimize Patient Outcomes, which standardized CMM in the context of the medical home. She serves as board president of the Alliance for Integrated Medication Management (AIMM).

Dr. McInnis received her Doctor of Medicine degree from Wake Forest Medical School and was designated a NIH student clinical scholar. She completed a residency in Occupational Medicine as an OPSF scholar, and a MPH (high honors) at the University of Oklahoma. She is Board Certified in Preventive and Occupational Medicine, a Fellow of the American College of Occupational and Environmental Medicine, and a Former Course Advisor to the Department of Continuing Education of Harvard University.


Additional Board Members

Sheila A. Haas, PhD, RN, FAAN

Loyola University

Chicago, IL


Andrea Iannucci, PharmD, BCOP

University of California, Davis Medical Center

Sacramento, CA


Peter G. Koval, PharmD, BCPS, CPP

UNC Eshelman School of Pharmacy

Chapel Hill, NC


Jerry McKee PharmD, MS, BCPP

Community Care of North Carolina

Raleigh, NC


Rebecca S. Miller, MS

Accreditation Council for Graduate Medical Education

Chicago, IL


Ex-Officio/ Non-Voting Members


Dennis K. Helling, PharmD, ScD (Hon), FCCP, FASHP, FAPhA

University of Colorado

Aurora, CO


William M. Ellis, RPh, MS

Executive Director of the Board of Pharmacy Specialties

Washington, DC


About the Board of Pharmacy Specialties

The Board of Pharmacy Specialties (BPS) was established in 1976 as an autonomous division of the American Pharmacists Association (APhA).  The mission of the Board of Pharmacy Specialties is to improve patient care and increase awareness of the need for BPS Board Certified Pharmacists as integral members of multidisciplinary healthcare teams through recognition and promotion of specialized training, knowledge, and skills in pharmacy and specialty board certification and recertification of pharmacists throughout the world.

Board Certification through BPS has become recognized as the gold standard for determining which pharmacists are qualified to contribute at advanced practice levels. Through the rigorous standards mandated by BPS board certification and recertification, the BPS board certified pharmacist stands out as the most qualified to accept today’s expanding professional expectations.  Currently over 20,000 pharmacists hold BPS Board Certification.

Press Release PDF